Emily Prieur is an IPilogue Writer and a 3L JD Candidate at Queen’s University Faculty of Law. Introduction In 2020, the Royal Swedish Academy of Sciences awarded the Nobel…
Tag: CRISPR
in Access to Medicines, Commercialization, Design, Development, IP, Patentability, Patents, Pharmaceutical Drugs, Uncategorized0by Editor
3180
What Makes It My Molecule: A Look at Professor Ronald Pearlman’s Genome Editing Work
This past November, Professor Ronald E. Pearlman from York University’s Department of Biology gave a talk [1] at Osgoode Hall Law School to discuss the potential of the innovative CRISPR…
More Money, More Problems: The Science, the Law, and the Fight over CRISPR Patents
From Lab Bench to Court Bench: The Science, the Law, and the CRISPR Patent Dispute Whenever a new technology has the potential to be ground-breaking and extremely valuable, there are…